Cargando…

Long-term persistence of SARS-CoV-2 neutralizing antibody responses after infection and estimates of the duration of protection

BACKGROUND: The duration of immunity in SARS-CoV-2 infected people remains unclear. Neutralizing antibody responses are the best available correlate of protection against re-infection. Recent studies estimated that the correlate of 50% protection from re-infection was 20% of the mean convalescent ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lau, Eric HY, Hui, David SC, Tsang, Owen TY, Chan, Wai-Hung, Kwan, Mike YW, Chiu, Susan S, Cheng, Samuel MS, Ko, Ronald LW, Li, John KC, Chaothai, Sara, Tsang, Chi H, Poon, Leo LM, Peiris, Malik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556690/ https://www.ncbi.nlm.nih.gov/pubmed/34746725 http://dx.doi.org/10.1016/j.eclinm.2021.101174

Ejemplares similares

The SARS-CoV-2 antibody landscape is lower in magnitude for structural proteins, diversified for accessory proteins and stable long-term in children
por: Hachim, Asmaa, et al.
Publicado: (2021)

SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection
por: Cohen, Carolyn A, et al.
Publicado: (2021)

Neutralizing antibody titres in SARS-CoV-2 infections
por: Lau, Eric H. Y., et al.
Publicado: (2021)

Lack of serological evidence of Middle East respiratory syndrome coronavirus infection in virus exposed camel abattoir workers in Nigeria, 2016
por: So, Ray TY, et al.
Publicado: (2018)

SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease
por: Perera, Ranawaka A.P.M., et al.
Publicado: (2020)

SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022
por: Cheng, Samuel MS, et al.
Publicado: (2022)

Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) (Coronaviridae)
por: Peiris, Malik, et al.
Publicado: (2021)

Plaque-neutralizing antibody to BA.2.12.1, BA.4 and BA.5 in individuals with three doses of BioNTech or CoronaVac vaccines, natural infection and breakthrough infection
por: Cheng, Samuel SM, et al.
Publicado: (2022)

Detection of SARS Coronavirus in Humans and Animals by Conventional and Quantitative (Real Time) Reverse Transcription Polymerase Chain Reactions
por: Peiris, J.S. Malik, et al.
Publicado: (2007)

Detection of Group 1 Coronaviruses in Bats Using Universal Coronavirus Reverse Transcription Polymerase Chain Reactions
por: Poon, Leo L.M., et al.
Publicado: (2007)

In-Flight Transmission of SARS-CoV-2
por: Choi, Edward M., et al.
Publicado: (2020)

Early season estimate of influenza vaccination effectiveness against influenza hospitalisation in children, Hong Kong, winter influenza season 2018/19
por: Chiu, Susan S, et al.
Publicado: (2019)

Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020
por: Perera, Ranawaka APM, et al.
Publicado: (2020)

Neutralizing antibody titres to SARS-CoV-2 Omicron variant and wild-type virus in those with past infection or vaccinated or boosted with mRNA BNT162b2 or inactivated CoronaVac vaccines
por: Peiris, Malik, et al.
Publicado: (2022)

Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS)
por: Seto, WH, et al.
Publicado: (2003)

SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection
por: Cohen, Carolyn A., et al.
Publicado: (2021)

Substitution at Aspartic Acid 1128 in the SARS Coronavirus Spike Glycoprotein Mediates Escape from a S2 Domain-Targeting Neutralizing Monoclonal Antibody
por: Ng, Oi-Wing, et al.
Publicado: (2014)

Codon usage bias and the evolution of influenza A viruses. Codon Usage Biases of Influenza Virus
por: Wong, Emily HM, et al.
Publicado: (2010)

Evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test for Detection of Antibody in Human, Canine, Cat, and Hamster Sera
por: Perera, Ranawaka A. P. M., et al.
Publicado: (2021)

Phylogenetic Analysis of MERS-CoV in a Camel Abattoir, Saudi Arabia, 2016–2018
por: Hemida, Maged Gomaa, et al.
Publicado: (2020)

Introduction of ORF3a-Q57H SARS-CoV-2 Variant Causing Fourth Epidemic Wave of COVID-19, Hong Kong, China
por: Chu, Daniel K.W., et al.
Publicado: (2021)

Natural Reassortment of Eurasian Avian-Like Swine H1N1 and Avian H9N2 Influenza Viruses in Pigs, China
por: Sun, Wanying, et al.
Publicado: (2022)

Heterologous influenza vRNA segments with identical non-coding sequences stimulate viral RNA replication in trans
por: Ng, Stella SF, et al.
Publicado: (2008)

The Cause of Severe Acute Respiratory Syndrome: What Did We Learn from It?
por: Peiris, Malik, et al.
Publicado: (2020)

Emergence of a novel human coronavirus threatening human health
por: Poon, Leo L. M., et al.
Publicado: (2020)

SARS-CoV-2 accessory proteins reveal distinct serological signatures in children
por: Hachim, Asmaa, et al.
Publicado: (2022)

SARS coronavirus 8b reduces viral replication by down-regulating E via an ubiquitin-independent proteasome pathway
por: Keng, Choong-Tat, et al.
Publicado: (2011)

SARS-CoV-2 Superspread in Fitness Center, Hong Kong, China, March 2021
por: Chu, Daniel K.W., et al.
Publicado: (2021)

Absence of MERS-Coronavirus in Bactrian Camels, Southern Mongolia, November 2014
por: Chan, Samuel M.S., et al.
Publicado: (2015)

A46 MERS-CoV in Arabian camels in Africa and Central Asia
por: Chu, Daniel K.W., et al.
Publicado: (2017)

Evidence-Based Options for Controlling Respiratory Virus Transmission
por: Cowling, Benjamin J., et al.
Publicado: (2017)

Detection of SARS Coronavirus
por: Peiris, J. S. Malik, et al.
Publicado: (2010)

Serologic Responses in Healthy Adult with SARS-CoV-2 Reinfection, Hong Kong, August 2020
por: Chan, Paul K.S., et al.
Publicado: (2020)

Immunogenicity of a Third Dose of BNT162b2 to Ancestral Severe Acute Respiratory Syndrome Coronavirus 2 and the Omicron Variant in Adults Who Received 2 Doses of Inactivated Vaccine
por: Leung, Nancy H L, et al.
Publicado: (2022)

Use of Sewage Surveillance for COVID-19: A Large-Scale Evidence-Based Program in Hong Kong
por: Deng, Yu, et al.
Publicado: (2022)

Absence of association between angiotensin converting enzyme polymorphism and development of adult respiratory distress syndrome in patients with severe acute respiratory syndrome: a case control study
por: Chan, KC Allen, et al.
Publicado: (2005)

Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population
por: Lau, Jonathan J., et al.
Publicado: (2023)

Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein
por: Han, Dong P, et al.
Publicado: (2004)

Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
por: Lv, Huibin, et al.
Publicado: (2020)

Longitudinal study of Middle East Respiratory Syndrome coronavirus infection in dromedary camel herds in Saudi Arabia, 2014–2015
por: Hemida, Maged Gomaa, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e9dtf8ff42vvsqjkmeupub66ak